FINANCIAL CHRONICLE™
Dear Reader,

Registration with the Sri Lanka FINANCIAL CHRONICLE™️ would enable you to enjoy an array of other services such as Member Rankings, User Groups, Own Posts & Profile, Exclusive Research, Live Chat Box etc..

All information contained in this forum is subject to Disclaimer Notice published.


Thank You
FINANCIAL CHRONICLE™️
www.srilankachronicle.com


Join the forum, it's quick and easy

FINANCIAL CHRONICLE™
Dear Reader,

Registration with the Sri Lanka FINANCIAL CHRONICLE™️ would enable you to enjoy an array of other services such as Member Rankings, User Groups, Own Posts & Profile, Exclusive Research, Live Chat Box etc..

All information contained in this forum is subject to Disclaimer Notice published.


Thank You
FINANCIAL CHRONICLE™️
www.srilankachronicle.com
FINANCIAL CHRONICLE™
Would you like to react to this message? Create an account in a few clicks or log in to continue.
FINANCIAL CHRONICLE™

Encyclopedia of Latest news, reviews, discussions and analysis of stock market and investment opportunities in Sri Lanka

LISTED COMPANIES

Submit Post



Poll

Can there be another Covid-19 wave in Sri Lanka?

Britain prepares for COVID-19 vaccine as Oxford forecasts result this year Vote_lcap68%Britain prepares for COVID-19 vaccine as Oxford forecasts result this year Vote_rcap 68% [ 178 ]
Britain prepares for COVID-19 vaccine as Oxford forecasts result this year Vote_lcap18%Britain prepares for COVID-19 vaccine as Oxford forecasts result this year Vote_rcap 18% [ 47 ]
Britain prepares for COVID-19 vaccine as Oxford forecasts result this year Vote_lcap13%Britain prepares for COVID-19 vaccine as Oxford forecasts result this year Vote_rcap 13% [ 35 ]

Total Votes : 260

STOCK MARKET TRAINING
ශ්‍රී ලංකා මූල්‍ය වංශකථාව - සිංහල
Submit Post


CONATCT US


Send your suggestions and comments

* - required fields

Read FINANCIAL CHRONICLE™ Disclaimer



Latest topics

» EXPOLANKA HOLDINGS PLC (EXPO.N0000)
by apple Today at 12:19 am

» CAL Initial Public Offer
by abey Today at 12:17 am

» HSenid IPO
by abey Today at 12:09 am

» CLC...DONT PANIC
by sureshot Yesterday at 10:53 pm

» Don't marry a stock, marry the idea of making money trading stocks. That's the only way to do it.
by Asoka Samarakone Yesterday at 9:03 pm

» Beware of Fabricated news on CLC
by Surajmp Yesterday at 6:55 pm

» LOLC Group Share Rise Imminent
by Winner123 Yesterday at 6:46 pm

» LOLC Advanced Technologies launches RT-LAMP Covid 19 Test Kit in Sri Lanka
by samaritan Yesterday at 4:37 pm

» NAMU/WATA super gain
by cseguide Yesterday at 12:20 pm

» WATA and other plantation stocks
by cseguide Yesterday at 12:17 pm

» SEMB.N and SEMB.X
by adjoseph Yesterday at 11:59 am

» LOFC Direction
by stockchaser Yesterday at 5:59 am

» CLC - Bull & Bear LOCKED HORNS - can blast at any time.
by D.G.Dayaratne Fri Dec 03, 2021 8:07 pm

» ඔමික්‍රෝන් ලංකාවට ඇතුලු වෙයි
by stockchaser Fri Dec 03, 2021 6:28 pm

» CLC - worth the Investment
by Captain Fri Dec 03, 2021 6:18 pm

» LOLC waiting for LOFC 100+ and CLC 100+
by Captain Fri Dec 03, 2021 6:17 pm

» Water For All - CIND
by LHW Fri Dec 03, 2021 5:37 pm

» COCR can be attractive
by C.THARANGA Fri Dec 03, 2021 1:22 pm

» SCAP just about to run
by Swissinvest Fri Dec 03, 2021 12:23 pm

» NP Rumored to enter SCAP
by Swissinvest Fri Dec 03, 2021 10:42 am

EXPERT CHRONICLE™

MARKET CHAT


CHRONICLE™ ANALYTICS


ECONOMIC CHRONICLE

GROSS DOMESTIC PRODUCT (GDP)


CHRONICLE™ YouTube

LATEST TWEETS

You are not connected. Please login or register

FINANCIAL CHRONICLE™ » CORPORATE CHRONICLE™ » Britain prepares for COVID-19 vaccine as Oxford forecasts result this year

Britain prepares for COVID-19 vaccine as Oxford forecasts result this year

Go down  Message [Page 1 of 1]

fireshelter

fireshelter
Associate Director - Equity Analytics
Associate Director - Equity Analytics

[size=34]Britain prepares for COVID-19 vaccine as Oxford forecasts result this year[/size]
Britain prepares for COVID-19 vaccine as Oxford forecasts result this year ReutersCoronavirus25 minutes ago (Nov 04, 2020 09:55AM ET)


 



Britain prepares for COVID-19 vaccine as Oxford forecasts result this year LYNXMPEGA30SU_L [size=11]:copyright: Reuters. FILE PHOTO: Small bottles labeled with "Vaccine" stickers stand near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration
By Alistair Smout and Guy Faulconbridge
LONDON (Reuters) - Late-stage trial results of a potential COVID-19 vaccine being developed by the University of Oxford and AstraZeneca (NYSE:AZN) could be presented this year as the British government prepares for a possible vaccination rollout in late December or early 2021.
A vaccine is seen as a game-changer in the battle against the coronavirus, which has killed more than 1.2 million people worldwide, shuttered swathes of the global economy and turned normal life upside down for billions of people.
There are more than 200 candidates under development and the vaccine being developed by Oxford and licensed to British drugmaker AstraZeneca (L:AZN) is seen as a front-runner.
"I'm optimistic that we could reach that point before the end of this year," Oxford Vaccine Trial Chief Investigator Andrew Pollard said of the chances of presenting trial results.
Pollard told British lawmakers that establishing whether or not the vaccine worked would likely come this year, after which the data would have to be carefully reviewed by regulators and then a political decision made on who should receive it.
"Our bit - we are getting closer to but we are not there yet," Pollard, director of the Oxford Vaccine Group, said.
Asked if he expected the vaccine would start to be deployed before Christmas, he said: "There is a small chance of that being possible but I just don't know."
The National Health Service (NHS) in England is preparing to start distributing possible COVID-19 vaccines before Christmas in case one is ready by the end of the year.
The Oxford/AstraZeneca vaccine is expected to be one of the first from big pharma to be submitted for regulatory approval, along with Pfizer (N:PFE) and BioNTech's (F:22UAy) candidate.
"If I put on my rose-tinted specs, I would hope that we will see positive interim data from both Oxford and from Pfizer/BioNTech in early December and if we get that then I think we have got the possibility of deploying by the year end," Kate Bingham, the chair of the UK Vaccine Taskforce, told lawmakers.
Prime Minister Boris Johnson said there was the prospect of a vaccine in the first quarter of 2021. AstraZeneca is presenting its third quarter financial results on Thursday.
'GAME CHANGER'
Work on the Oxford viral vector vaccine, called AZD1222 or ChAdOx1 nCoV-19, began in January. It is made from a weakened version of a common cold virus that causes infections in chimpanzees.
The chimpanzee cold virus has been genetically changed to include the genetic sequence of the so-called spike protein which the coronavirus uses to gain entry to human cells. The hope is that the human body will then attack the novel coronavirus if it sees it again.
If Oxford's vaccine works, it could eventually allow the world to return to some measure of normality.
Asked what success looked like, Pollard said: "Good is having vaccines that have significant efficacy - so whether, I mean, that is 50, 60, 70, 80 percent, whatever the figure is - is an enormous achievement.
"It's a complete game changer and a success if we meet those efficacy end points," he said, adding it would relieve pressure on the health system.
But Pollard and Bingham agreed that the world would not return to normal immediately. Asked about the chances of a vaccine that would wipe out the coronavirus next year, Bingham said the prospects were "very slim".

"(But the chances) to get a vaccine that has an effect of both reducing illness, and reducing mortality (are) very high," Bingham said, adding she was more than 50% confident there would be such a vaccine by early summer.[/size]

Back to top  Message [Page 1 of 1]

Permissions in this forum:
You cannot reply to topics in this forum